Aspirin inhibits the carcinogenesis of esophageal squamous cell carcinoma and enhances its responses to cisplatin

被引：0
|
作者：
Zou, Zhigeng
Fan, Hongjun
Yu, Xiying
Zhang, Shuming
Guo, Liping
Jiang, Wei
Lu, Shih-Hsin
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1262
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1262
引用
收藏
页数：2
相关论文
共 50 条
  • [21] ADAMTS8Inhibits Progression of Esophageal Squamous Cell Carcinoma
    Wu, Zhonglin
    Shi, Yanjun
    Ren, Shuguang
    Ju, Yingchao
    Hu, Yueyang
    Wu, Jianhua
    DNA AND CELL BIOLOGY, 2020, 39 (12) : 2300 - 2307
  • [22] Downregulation of Ubiquitin Inhibits the Aggressive Phenotypes of Esophageal Squamous Cell Carcinoma
    Gao, Yi
    Mo, Wei
    Zhong, Li
    Jia, Huimin
    Xu, Yiren
    Zhang, Ji
    Xu, Xiaohui
    Shen, Weidong
    Wang, Fangjun
    Li, Tengfei
    Liu, Pengfei
    Zhang, Shuyu
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [23] Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma
    Honda, M.
    Miura, A.
    Izumi, Y.
    Kato, T.
    Ryotokuji, T.
    Monma, K.
    Fujiwara, J.
    Egashira, H.
    Nemoto, T.
    DISEASES OF THE ESOPHAGUS, 2010, 23 (08) : 641 - 645
  • [24] Definitive chemoradiotherapy with capecitabine and cisplatin in elder patients with squamous cell esophageal carcinoma
    Xing, Ligang
    Zhang, Jiandong
    Wang, Fuli
    Liu, Fengjun
    Yu, Xinshuang
    Song, Meijuan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] ASSOCIATION VINDESINE, CYCLOPHOSPHAMIDE, CISPLATIN AND CCNU IN ESOPHAGEAL SQUAMOUS-CELL CARCINOMA
    SPIELMANN, M
    KAC, J
    ELIAS, D
    CAILLE, P
    LECHEVALIER, T
    ROUGIER, P
    ZUMMER, K
    LASSER, P
    ROUESSE, J
    BULLETIN DU CANCER, 1985, 72 (03) : 220 - 226
  • [26] HA15 inhibits binding immunoglobulin protein and enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma
    Luo, Hui
    Wang, Liuxiang
    Zhang, Deju
    Sun, Yanan
    Wang, Shujuan
    Song, Shuai
    Ge, Hong
    CANCER SCIENCE, 2023, 114 (04) : 1697 - 1709
  • [27] Neoadjuvant chemoradiotherapy with cisplatin plus vinorelbine versus cisplatin plus fluorouracil for esophageal squamous cell carcinoma
    Xi, M.
    Zhang, L.
    Liu, S. L.
    Liu, M. Z.
    Yang, H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S406 - S406
  • [28] Y-box-binding protein 1 promotes tumor progression and inhibits cisplatin chemosensitivity in esophageal squamous cell carcinoma
    Xu, Jing
    Hu, Zhendong
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 79 : 17 - 22
  • [29] ESOPHAGEAL SQUAMOUS CELL CARCINOMA
    Hakami, Bassam Ali Othman
    Faqih, Yazeed Abdullah Hassan
    Hakami, Maria Ali Othman
    Hakam, Norah Ali Othman
    Hakami, Arwa Ali Othman
    Zalah, Amal Ahmed Abdullah
    Hakami, Awsam Mohammed Shaoush
    Almalki, Naser Husein Yahia
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (01): : 1304 - 1312
  • [30] DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma
    Y Zhou
    L Wang
    X Ban
    T Zeng
    Y Zhu
    M Li
    X-Y Guan
    Y Li
    Oncogene, 2018, 37 : 1086 - 1094
12345